Variation of DNA copies number in etiology of congenital heart defects

by A. A. Slepukhina, I. N. Lebedev, G. I. Lifshitz
Published 2018-11-01

PLASMINOGEN ACTIVATOR INHIBITOR GENE POLYMORPHISM IN EVALUATION OF THE VARIOUS LOCALIZATION THROMBOSIS RISKS (PILOT STUDY)

by A. I. Subbotovskaya, G. A. Tsvetovskaya, A. A. Slepukhina, G. I. Lifshitz
Published 2015-10-01

ASSOCIATION OF THE GENE CYP11B2 WITH THE RISK OF ESSENTIAL HYPERTENSION AND ATHEROTHROMBOTIC COMPLICATIONS

by E. M. Zelenskaya, N. V. Koch, V. V. Kireeva, K. A. Apartsin, G. I. Lifshitz
Published 2016-06-01

THE USE OF A NEW APPROACH TO PREVENTION AND THERAPY OF ACUTE ARTERIAL HYPERTENSION WITH COMPLEX OF WELL-KNOWN DRUGS WITH VEGETABLE GLYCOSIDES (EXPERIMENTAL STUDY)

by T. G. Tolstikova, I. V. Sorokina, A. O. Brisgalov, M. P. Dolgich, G. I. Lifshitz, M. V. Chvostov
Published 2016-01-01

THE “PROTOCOL” STUDY: PRELIMINARY RESULTS

by E. M. Zelenskaya, A. I. Subbotovskaya, V. I. Ganyukov, N. A. Kochergin, V. B. Barbarich, N. O. Saraeva, A. V. Vybivantseva, K. A. Apartsin, G. I. Lifshitz
Published 2015-10-01

Regional aspects of associations of the CYP2C19 gene polymorphism with coronary atherosclerosis in acute coronary syndrome

by K. Yu. Nikolaev, I. A. Urvantseva, K. Yu. Batueva, K. A. Apartsin, A. V. Gorokhova, V. I. Ganyukov, N. A. Kochergin, E. M. Zelenskaya, G. I. Lifshitz
Published 2018-11-01